Ubs Group Ag Equillium, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Equillium, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 28,030 shares of EQ stock, worth $28,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,030

Previous 83,551 66.45%

Holding current value

$28,590

Previous $26,000 53.85%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$0.32 - $2.25 $17,766 - $124,922	-55,521 Reduced 66.45%	28,030 $40,000
Q2 2025 Aug 14, 2025	BUY	$0.29 - $0.5 $23,730 - $40,914	81,829 Added 4751.97%	83,551 $26,000
Q1 2025 May 13, 2025	SELL	$0.39 - $0.94 $6,078 - $14,651	-15,587 Reduced 90.05%	1,722 $0
Q4 2024 Feb 14, 2025	SELL	$0.6 - $1.38 $1,225 - $2,817	-2,042 Reduced 10.55%	17,309 $13,000
Q3 2024 Nov 14, 2024	BUY	$0.64 - $1.13 $8,360 - $14,762	13,064 Added 207.79%	19,351 $16,000

Q2 2024 Aug 13, 2024	BUY	$0.66 - $2.33 $4,149 - $14,648	6,287 New	6,287 $4,000
Q1 2023 May 12, 2023	SELL	$0.56 - $1.24 $4,762 - $10,544	-8,504 Reduced 58.46%	6,043 $4,000
Q4 2022 Feb 08, 2023	BUY	$0.83 - $2.26 $10,278 - $27,987	12,384 Added 572.54%	14,547 $15,000
Q3 2022 Nov 10, 2022	BUY	$1.93 - $3.14 $3,016 - $4,907	1,563 Added 260.5%	2,163 $5,000
Q2 2022 Aug 10, 2022	SELL	$1.69 - $3.26 $2,095 - $4,042	-1,240 Reduced 67.39%	600 $1,000
Q1 2022 May 16, 2022	BUY	$2.99 - $4.19 $5,501 - $7,709	1,840 New	1,840 $6,000
Q3 2021 Nov 15, 2021	SELL	$4.84 - $6.91 $2,570 - $3,669	-531 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.11 - $7.64 $843 - $1,260	-165 Reduced 23.71%	531 $3,000
Q1 2021 May 12, 2021	SELL	$5.03 - $10.5 $121,454 - $253,533	-24,146 Reduced 97.2%	696 $5,000
Q4 2020 Feb 11, 2021	BUY	$3.48 - $6.58 $86,450 - $163,460	24,842 New	24,842 $133,000
Q3 2020 Nov 12, 2020	SELL	$2.78 - $26.5 $6,819 - $65,004	-2,453 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$2.34 - $3.53 $5,740 - $8,659	2,453 New	2,453 $7,000
Q1 2020 May 01, 2020	SELL	$2.3 - $5.5 $3,077 - $7,359	-1,338 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.0 - $5.0 $5,487 - $9,145	-1,829 Reduced 57.75%	1,338 $5,000
Q3 2019 Nov 14, 2019	BUY	$3.31 - $5.6 $7,493 - $12,678	2,264 Added 250.72%	3,167 $12,000
Q2 2019 Aug 14, 2019	BUY	$5.28 - $8.2 $4,767 - $7,404	903 New	903 $5,000
Q1 2019 May 14, 2019	SELL	$5.84 - $12.02 $11,154 - $22,958	-1,910 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $12,071 - $37,130	1,910 New	1,910 $16,000

Others Institutions Holding EQ

# of Institutions

Shares Held

32.3M

Call Options Held

152K

Put Options Held

View Full List

About Equillium, Inc.

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $35M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

More about EQ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account